Reaching consensus is a challenge for any community, and the global health care community is no exception.

According to new research from the World Health Organization, the treatment and prevention of non-communicable diseases have been “severely disrupted” since the pandemic began.

Los lideres y advocates de pacientes en América Latina están explorando como las políticas inteligentes pueden fomentar la innovación y proteger el acceso de los pacientes durante COVID-19.

Patient advocates across Latin America are exploring how smart policy can encourage innovation and protect patient access during COVID-19.

Last month patient groups and Members of the European Parliament pledged to “leave no-one behind” in their response to the COVID-19 pandemic.

“COVID phobia” has increased the novel coronavirus’ collateral damage by stopping high-risk patients from seeking necessary care.

With the world’s attention on new and re-emerging outbreaks of COVID-19, advocates are working towards policies that ensure care for overshadowed patient groups.

As the COVID-19 pandemic drives a global telemedicine revolution, one Latin American initiative is proving the value of remote care.

As policymakers grapple with whether, or when, to end coronavirus lockdowns, patient advocacy organisations continue to urge policies that protect people with chronic disease.

As the COVID-19 crisis grows, policymakers may be overlooking a vulnerable population: patients living with rheumatic and musculoskeletal diseases like rheumatoid arthritis.